REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/01/2026
Back to search
Official data from USPTO
MIQURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MIQURE
ST13
US500000088377819Class
5, 42, 44
Filing
88377819
Registration
6367204
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/02/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
04/09/2019
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
26
Owner location
AMSTERDAM, NL
Examiner
PARADEWELAI, BENJI YUEN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
UNIQURE BIOPHARMA B.V.
uniQure IP B.V.
Representatives
Julianne Abelman ABELMAN LAW PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseasesviral systemsgene therapy systemsnucleic acid delivery systemsviral vectorsnon-viral vectorsgene therapy vectorsnucleic acid delivery vectorscells transformed by viral vectorsnon-viral vectorsgene therapy vectors or nucleic acid delivery vectors; Viral systemsgene therapy systemsnucleic acid delivery systems for medical purposesmedicines for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; Pharmaceutical preparations and substances for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; biological preparations for use in medical and clinical gene therapynucleic acid-based therapy and cell therapy for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapygene therapycell therapygene diagnosis and gene testing; pharmaceutical preparationsvaccinesprophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapygene therapy and cell therapy for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases
Class 42
Researchproduct development and consultancy in the field of biotechnologybiologicsmedical sciencechemistry and biochemistry; Research and product development in the field of pharmaceutics
Class 44
Gene and nucleic acid deliverygene and nucleic acid transfergene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disordersocular disordersdiseases of the nervous systemblood disordersliver disordersmuscular disordersmuscular skeletal disorderscancersinfectious diseasesinflammatory and auto-immune diseasesvascular disordersinherited disordersgenetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Publications
History of USPTO decisions and trademark events.
42 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/11/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/26/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/26/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/16/2021
PUBO
PUBLISHED FOR OPPOSITION
03/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/24/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/08/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/28/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/11/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/05/2019
CNSL
SUSPENSION LETTER WRITTEN
12/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2019
ALIE
ASSIGNED TO LIE
12/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/24/2019
GNRT
NON-FINAL ACTION E-MAILED
06/24/2019
CNRT
NON-FINAL ACTION WRITTEN
06/24/2019
DOCK
ASSIGNED TO EXAMINER
06/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2019
NWAP
NEW APPLICATION ENTERED
04/12/2019
Continuous trademark protection
Get notified about every new filing that threatens MIQURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.